74 related articles for article (PubMed ID: 38495740)
21. Sepsis and septic shock.
Hotchkiss RS; Moldawer LL; Opal SM; Reinhart K; Turnbull IR; Vincent JL
Nat Rev Dis Primers; 2016 Jun; 2():16045. PubMed ID: 28117397
[TBL] [Abstract][Full Text] [Related]
22. The RCSB protein data bank: integrative view of protein, gene and 3D structural information.
Rose PW; Prlić A; Altunkaya A; Bi C; Bradley AR; Christie CH; Costanzo LD; Duarte JM; Dutta S; Feng Z; Green RK; Goodsell DS; Hudson B; Kalro T; Lowe R; Peisach E; Randle C; Rose AS; Shao C; Tao YP; Valasatava Y; Voigt M; Westbrook JD; Woo J; Yang H; Young JY; Zardecki C; Berman HM; Burley SK
Nucleic Acids Res; 2017 Jan; 45(D1):D271-D281. PubMed ID: 27794042
[TBL] [Abstract][Full Text] [Related]
23. Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes.
Gupta S; Sakhuja A; Kumar G; McGrath E; Nanchal RS; Kashani KB
Chest; 2016 Dec; 150(6):1251-1259. PubMed ID: 27615024
[TBL] [Abstract][Full Text] [Related]
24. Protein Structure and Function Prediction Using I-TASSER.
Yang J; Zhang Y
Curr Protoc Bioinformatics; 2015 Dec; 52():5.8.1-5.8.15. PubMed ID: 26678386
[TBL] [Abstract][Full Text] [Related]
25. Lead- and drug-like compounds: the rule-of-five revolution.
Lipinski CA
Drug Discov Today Technol; 2004 Dec; 1(4):337-41. PubMed ID: 24981612
[TBL] [Abstract][Full Text] [Related]
26. Sepsis: current dogma and new perspectives.
Deutschman CS; Tracey KJ
Immunity; 2014 Apr; 40(4):463-75. PubMed ID: 24745331
[TBL] [Abstract][Full Text] [Related]
27. Severe sepsis and septic shock.
Angus DC; van der Poll T
N Engl J Med; 2013 Aug; 369(9):840-51. PubMed ID: 23984731
[No Abstract] [Full Text] [Related]
28. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties.
Cheng F; Li W; Zhou Y; Shen J; Wu Z; Liu G; Lee PW; Tang Y
J Chem Inf Model; 2012 Nov; 52(11):3099-105. PubMed ID: 23092397
[TBL] [Abstract][Full Text] [Related]
29. Quantifying the chemical beauty of drugs.
Bickerton GR; Paolini GV; Besnard J; Muresan S; Hopkins AL
Nat Chem; 2012 Jan; 4(2):90-8. PubMed ID: 22270643
[TBL] [Abstract][Full Text] [Related]
30. In silico exploration of anti-inflammatory activity of natural coumarinolignoids.
Meena A; Yadav DK; Srivastava A; Khan F; Chanda D; Chattopadhyay SK
Chem Biol Drug Des; 2011 Oct; 78(4):567-79. PubMed ID: 21736704
[TBL] [Abstract][Full Text] [Related]
31. Novel insights for systemic inflammation in sepsis and hemorrhage.
Cai B; Deitch EA; Ulloa L
Mediators Inflamm; 2010; 2010():642462. PubMed ID: 20628562
[TBL] [Abstract][Full Text] [Related]
32. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia.
Abe R; Oda S; Sadahiro T; Nakamura M; Hirayama Y; Tateishi Y; Shinozaki K; Hirasawa H
Crit Care; 2010; 14(2):R27. PubMed ID: 20202204
[TBL] [Abstract][Full Text] [Related]
33. MetaPocket: a meta approach to improve protein ligand binding site prediction.
Huang B
OMICS; 2009 Aug; 13(4):325-30. PubMed ID: 19645590
[TBL] [Abstract][Full Text] [Related]
34. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
[TBL] [Abstract][Full Text] [Related]
35. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4.
Roger T; Froidevaux C; Le Roy D; Reymond MK; Chanson AL; Mauri D; Burns K; Riederer BM; Akira S; Calandra T
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2348-52. PubMed ID: 19181857
[TBL] [Abstract][Full Text] [Related]
36. Shared principles in NF-kappaB signaling.
Hayden MS; Ghosh S
Cell; 2008 Feb; 132(3):344-62. PubMed ID: 18267068
[TBL] [Abstract][Full Text] [Related]
37. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.
Vogl T; Tenbrock K; Ludwig S; Leukert N; Ehrhardt C; van Zoelen MA; Nacken W; Foell D; van der Poll T; Sorg C; Roth J
Nat Med; 2007 Sep; 13(9):1042-9. PubMed ID: 17767165
[TBL] [Abstract][Full Text] [Related]
38. Chemical and biological aspects of Narcissus alkaloids.
Bastida J; Lavilla R; Viladomat F
Alkaloids Chem Biol; 2006; 63():87-179. PubMed ID: 17133715
[TBL] [Abstract][Full Text] [Related]
39. Management of sepsis.
Russell JA
N Engl J Med; 2006 Oct; 355(16):1699-713. PubMed ID: 17050894
[No Abstract] [Full Text] [Related]
40. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.
Sunahori K; Yamamura M; Yamana J; Takasugi K; Kawashima M; Yamamoto H; Chazin WJ; Nakatani Y; Yui S; Makino H
Arthritis Res Ther; 2006; 8(3):R69. PubMed ID: 16613612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
